Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial (IUD@CSD)

This study is currently recruiting participants.
Verified April 2013 by University of North Carolina, Chapel Hill
Sponsor:
Collaborator:
Society of Family Planning
Information provided by (Responsible Party):
Erika Levi, MD, MPH, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01539759
First received: February 21, 2012
Last updated: April 3, 2013
Last verified: April 2013

February 21, 2012
April 3, 2013
February 2012
December 2013   (final data collection date for primary outcome measure)
IUD use [ Time Frame: 6 months postpartum ] [ Designated as safety issue: No ]
The use of an IUD at 6 months postpartum is the primary outcome measure
Same as current
Complete list of historical versions of study NCT01539759 on ClinicalTrials.gov Archive Site
  • IUD Expulsion [ Time Frame: 0-6 months postpartum ] [ Designated as safety issue: No ]
  • Women's satisfaction with IUDs [ Time Frame: 0-6 months postpartum ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
Immediate Postplacental Insertion of Intrauterine Devices at Time of Cesarean Delivery: A Randomized Clinical Trial

This is a randomized controlled trial among women who deliver by cesarean at UNC Women's Hospital and desire an Intrauterine Device (IUD) for contraception postpartum. After consenting, women will be randomized to receive an IUD at time of cesarean delivery or at a postpartum visit 4-8 weeks later. After randomization, subjects will be given a choice of the Mirena® IUD or the Paragard® IUD. Data collection will occur at baseline, delivery, the 4-8 week postpartum visit, and 2 follow-up encounters at 3 and 6 months. We hypothesize that women who receive an IUD at the time of cesarean will be more likely to use an IUD 6 months later than women who plan on receiving an IUD 4-8 weeks after delivery.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Intrauterine Devices
  • Cesarean Section
Device: Immediate Postplacental Placement of an IUD during cesarean delivery
Women randomized to this arm will have an IUD placed during their cesarean delivery, immediately after delivery of the placenta
  • No Intervention: Interval IUD Placement
    Women randomized to this arm will be scheduled for their IUD placement 4-8 weeks after their cesarean delivery
  • Experimental: Immediate Postplacental IUD placement
    Women randomized to this arm will receive on IUD at time of cesarean delivery, immediately after the delivery of the placenta
    Intervention: Device: Immediate Postplacental Placement of an IUD during cesarean delivery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
112
December 2013
December 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women ages 18-45
  • Pregnant and greater than or equal to 24 weeks of estimated gestational age
  • Live Pregnancy
  • States a plan to use an Intrauterine Device (IUD) postpartum for contraception
  • Plan for cesarean delivery
  • Intend to stay in the Chapel Hill area for at least 6 months after birth
  • Fluent in English or Spanish

Exclusion Criteria:

  • known uterine anomalies
  • allergies to any component of the IUD of their choosing
  • known or suspected carcinoma of the breast
  • known acute liver disease or liver tumor (benign or malignant)
  • known or suspected uterine or cervical neoplasia
  • active pelvic inflammatory disease
  • genital bleeding of unknown etiology
  • history of solid organ transplantation
  • positive test for gonorrhea or chlamydia during this pregnancy
Female
18 Years to 45 Years
No
Contact: Erika Levi, MD, MPH 919-843-8066 Erika_Levi@med.unc.edu
Contact: Gretchen Stuart, MD 919-966-7783 gstuart@med.unc.edu
United States
 
NCT01539759
11-2477
Yes
Erika Levi, MD, MPH, University of North Carolina, Chapel Hill
University of North Carolina, Chapel Hill
Society of Family Planning
Principal Investigator: Erika Levi, MD University of North Carolina, Chapel Hill
University of North Carolina, Chapel Hill
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP